Prevent Professional Research Subjects With Verified Clinical Trials

Professional research subjects cause issues with placebo rates, data quality and safety.  The issue is more common than most would think.  Upwards of 10% of research subjects will attempt to enroll in more than one clinical trial concurrently or before a safe and mandatory wash out period has occurred. Without a tool like Verified Clinical …

Read more

Duplicate Or Professional Research Subjects Result In Failed Clinical Trials

Duplicate or professional research subjects can be the silent killer of your clinical trial. The issue exists in all phases of clinical trials research, across the globe and across most therapeutic areas. As the data grows, we realize how important it is to use the Verified Clinical Trials (VCT) research subject registry to prevent these …

Read more

Verified Clinical Trials Sees Progress In The Understanding and Acceptance of Duplicate Subjects In Clinical Trials

We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials  or professional research subjects over the past few years.  Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …

Read more

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and  as well as other protocol violations. The workshop …

Read more

Subject Registries Reduce Duplicate Subjects Entering CNS Studies

Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations.  Up to 10% in CNS clinical trials and much higher …

Read more

Case Study: Duplicate Subjects In Clinical Trials Cause Failure To Meet Endpoints

Your clinical trial is not meeting it’s endpoints and upon review, you detect there are duplicate subjects in your study. You and your teams spend several months trying to weed out these duplicate subjects. A new study must be performed. We hear this all the time. It occurs across most therapeutic indications and across the …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Verified Clinical Trials Partners With The STARR Coalition To Promote Advocacy And Reduce Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …

Read more

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more